検索
IRIDEX Corp
IRIXウォッチリストに追加
0.820USD
-0.001-0.13%
終値 07-31 16:00（ET）15分遅れの株価
13.98M時価総額
損失額直近12ヶ月PER
詳細情報 IRIDEX Corp 企業名
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
IRIDEX Corpの企業情報
企業コードIRIX
会社名IRIDEX Corp
上場日Feb 16, 1996
最高経営責任者「CEO」Mercer (Patrick)
従業員数93
証券種類Ordinary Share
決算期末Feb 16
本社所在地1212 Terra Bella Ave
都市MOUNTAIN VIEW
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94043
電話番号16509404700
ウェブサイトhttps://www.iridex.com/
企業コードIRIX
上場日Feb 16, 1996
最高経営責任者「CEO」Mercer (Patrick)
IRIDEX Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
262.07K
+38.16%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
140.78K
+21.31%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
262.07K
+38.16%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
140.78K
+21.31%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
よくある質問
IRIDEX Corpの上位5名の株主は誰ですか？
IRIDEX Corpの上位5名の株主は以下のとおりです。Mr. William M. (Will) Moore, Jr.
IRIDEX Corp（IRIX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、IRIDEX Corpの株式を保有している機関は52社あり、保有株式の総市場価値は約3.69Mで、全体の21.29%を占めています。2025Q4と比較して、機関の持ち株は278304.00増加しています。
IRIDEX Corpの最大の収益源は何ですか？
2026Q1において、Retina部門がIRIDEX Corpにとって最大の収益を生み出しており、その金額は6.70Mで、全収益の53.65%を占めています。